Human Genome Epidemiology Literature Finder
|
Records 1 - 27 (of 27 Records) |
| Query Trace: Lung Neoplasms and NOTCH1[original query] |
|---|
| Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection? International journal of molecular sciences 2015 16 (1): 747-57. Ulivi Paola, Delmonte Angelo, Chiadini Elisa, Calistri Daniele, Papi Maximilian, Mariotti Marita, Verlicchi Alberto, Ragazzini Angela, Capelli Laura, Gamboni Alessandro, Puccetti Maurizio, Dubini Alessandra, Burgio Marco Angelo, Casanova Claudia, Crinò Lucio, Amadori Dino, Dazzi Claud |
| Hot spot mutations in Finnish non-small cell lung cancers. Lung cancer (Amsterdam, Netherlands) 2016 Sep 99 102-10. Mäki-Nevala Satu, Sarhadi Virinder Kaur, Rönty Mikko, Kettunen Eeva, Husgafvel-Pursiainen Kirsti, Wolff Henrik, Knuuttila Aija, Knuutila Saka |
| A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
| Single nucleotide polymorphism rs3124599 in Notch1 is associated with the risk of lung cancer in northeast Chinese non-smoking females. Oncotarget 2017 Mar . Quan Xiaowei, Yin Zhihua, Fang Xue, Zhou Baos |
| Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 113-121. Du Meijun, Thompson Jonathan, Fisher Hannah, Zhang Peng, Huang Chiang-Ching, Wang Lia |
| Cigarette smoke enhances initiation and progression of lung cancer by mutating Notch1/2 and dysregulating downstream signaling molecules. Oncotarget 2018 2 8 (70): 115128-115139. Li Wei, Zhou Jihong, Chen Yuqing, Zhang Gengyan, Jiang Peng, Hong Lei, Shen Yuangbing, Wang Xiaojing, Gong Xiaome |
| Mutation Profile of Resected EGFR-Mutated Lung Adenocarcinoma by Next-Generation Sequencing. The oncologist 2019 3 24 (10): 1368-1374. Zhao Ze-Rui, Lin Yao-Bin, Ng Calvin S H, Zhang Rong, Wu Xue, Ou Qiuxiang, Chen Wendan, Zhou Wen-Jie, Lin Yong-Bin, Su Xiao-Dong, Shao Yang W, Long H |
| Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation. Oncogene 2019 Nov . Jin Ying, Bao Hua, Le Xiuning, Fan Xiaojun, Tang Ming, Shi Xun, Zhao Jun, Yan Junrong, Xu Yang, Quek Kelly, Elamin Yasir Y, Zhang Jianhua, Futreal P Andrew, Wistuba Ignacio I, Heymach John V, Lou Guangyuan, Shao Lan, He Qiong, Lin Chen, Wu Xue, Shao Yang W, Wang Xiaonan, He Jiachen, Chen Yamei, Stebbing Justin, Chen Ming, Zhang Jianjun, Yu Xinm |
| Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. Journal for immunotherapy of cancer 2020 8 8 (2): . Mazzotta Marco, Filetti Marco, Occhipinti Mario, Marinelli Daniele, Scalera Stefano, Terrenato Irene, Sperati Francesca, Pallocca Matteo, Rizzo Francesco, Gelibter Alain, Botticelli Andrea, Scafetta Giorgia, Di Napoli Arianna, Krasniqi Eriseld, Pizzuti Laura, Barba Maddalena, Carpano Silvia, Vici Patrizia, Fanciulli Maurizio, De Nicola Francesca, Ciuffreda Ludovica, Goeman Frauke, De Maria Ruggero, Vecchione Andrea, Giusti Raffaele, Ciliberto Gennaro, Marchetti Paolo, Maugeri-Saccà Marcel |
| Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 4 26 (14): 3649-3661. Zhang Kai, Hong Xiaohua, Song Zhengbo, Xu Yu, Li Chengcheng, Wang Guoqiang, Zhang Yuzi, Zhao Xiaochen, Zhao Zhengyi, Zhao Jing, Huang Mengli, Huang Depei, Qi Chuang, Gao Chan, Cai Shangli, Gu Feifei, Hu Yue, Xu Chunwei, Wang Wenxian, Lou Zhenkun, Zhang Yong, Liu |
| Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma. Frontiers in oncology 2020 10 607130. Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe |
| [Analysis of the feasibility and prognostic value of circulating tumor DNA in detecting gene mutations in small cell lung cancer]. Zhonghua yi xue za zhi 2020 12 100 (45): 3614-3621. Jin Y, Chen Y M, Hu X, Tang H R, Yu X M, Fan Y, Xu Y J, Xu H M, Li P S, Li Q, Chang L P, Guan Y F, Chen |
| Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing. Journal of thoracic disease 2021 Aug 13 (8): 5007-5015. Zhang Fan, Wang Junyan, Ma Minting, Xu Yu, Lu Xiangjun, Wei Su |
| Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis. Frontiers in oncology 2021 6 11 630672. Wan Lingling, Liu Qingyi, Liang Di, Guo Yongdong, Liu Guangjie, Ren Jinxia, He Yutong, Shan Bao |
| Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung. Cell death & disease 2021 May 12 (5): 472. Song Zhengbo, Liu Yueping, Cheng Guoping, Chang Lianpeng, Yu Zicheng, Chen Ming, Chen Ga |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 12 112 (5): 1165-1176. Li Li, Tang Shanshan, Yin Jiani C, Dong Lihua, Yang Zhe, Liu Yueping, Ma Jie, Chang Pengyu, Pang Jiaohui, Bao Hua, Mu Dianbin, Zheng Xiaoli, Aishajiang Reyida, He Kewen, Zhang Shaotong, Ni Meng, Wu Xue, Wang Xiaonan, Shao Yang, Wang Jun, Ge Hong, Yu Jinming, Yuan Shuang |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. Frontiers in medicine 2022 9 808378. Peng Jie, Xiao Lushan, Zou Dan, Han Lij |
| Characteristics of Notch signaling pathway and its correlation with immune microenvironment in SCLC. Lung cancer (Amsterdam, Netherlands) 2022 4 167 25-33. Li Wei, Ye Lingyun, Huang Yan, Zhou Fei, Wu Chunyan, Wu Fengying, He Yayi, Li Xuefei, Wang Haowei, Xiong Anwen, Gao Guanghui, Wang Lei, Su Chunxia, Ren Shengxiang, Chen Xiaoxia, Zhou Caic |
| Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
| Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 18 (1): 93-105. Zhou Caicun, Huang Dingzhi, Fan Yun, Yu Xinmin, Liu Yunpeng, Shu Yongqian, Ma Zhiyong, Wang Ziping, Cheng Ying, Wang Jie, Hu Sheng, Liu Zhihua, Poddubskaya Elena, Disel Umut, Akopov Andrey, Dvorkin Mikhail, Zheng Wenjuan, Ma Yiyuan, Wang Yan, Li Songzi, Yu Cunjing, Rivalland Gare |
| Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing. Neoplasma 2022 Jan . Zhang Hui, Jiang Da, Jin Hui, Cui Yan-Zhi, Wei Su-Ju, Li Ying, Dong Qian, Zuo Jing, Tian Cai-Juan, Yan Fang, Wang Xiao-W |
| Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
| NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. ImmunoTargets and therapy 2023 12 12 165-173. Qingyuan Huang, Hang Cao, Qianlan Yao, Xiaoyan Zhou, Hang Li, Qianming Bai, Hong |
| NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Molecular oncology 2023 10 . Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen-Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nish |
| Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
- Page last reviewed:Feb 1, 2024
- Content source: